Golden Helix Featured in Various Publications

         July 8, 2020

Golden Helix has been incredibly fortunate to have been featured in a variety of publications over these last six months. Topics span from the history and future of our company to several new use cases for our solutions that extend into the infectious disease space, recently coming to fruition with the COVID-19 pandemic.

We are so grateful to have received this recognition. We hope you find this round-up to be helpful in learning more about Golden Helix and our team’s focus on quality innovation in the Next-Gen Sequencing space.

Top 10 World’s Most Trust Worthy Bioanalysis Companies in 2020 – CIO Look

March 13, 2020 | Biotech is one of the fastest-growing sectors in the world as data continues to drive the development of biotechnology solutions to advance the healthcare system. With the aim to bring advancements in genomic data and Next-Generation Sequencing (NGS), Golden Helix enables clinicians and researchers to conduct advanced analytics on genomic data with full scalability, workflow automation and the ability to capture and query a lab’s entire output. The Montana based biotech firm has been in business for over 20 years supporting and streamlining the clinical decision-making process for NGS clients in over 400 organizations with 1,000s of users worldwide… Continue Reading >

2020 Biotechnology Awards – Global Health & Pharma

April 6, 2020 | Covering a variety of verticals, including bio agriculture, bio services, bio industrial, and biopharmaceutical, the biotechnology market are under the microscope in Global Health & Pharma’s Biotechnology Awards. Boasting impressive market value growth with no signs of slowing, endeavors in biotechnology continue to make advancements in the laboratories as well as in the boardrooms, advancements which improve the lives of all, across the globe… Continue Reading >

Best Practices for NGS-Based Cancer Diagnostics – The Journal of Precision Medicine

April 9, 2020 | Precision Medicine is based on gathering and analyzing genomic, proteomic, and clinical data from large populations of patients to stratify patients into subpopulations with common traits, health conditions, or response to drugs. For individual patients, these data can then be used to recommend the best actionable clinical decisions in the following areas: Diagnosis, Treatment, Prevention… Continue Reading >

Leveraging Next-Generation Sequencing Technology in the Fight Against COVID-19 – Clinical Lab Manager

May 4, 2020 | With the help of NGS, we can enhance our understanding of the virus and its underlying pathways impacting humans. The current lockdown of the country due to the COVID-19 pandemic will be difficult to sustain, especially for the extended period required to develop a vaccine. Most public health experts agree that the key component needed to reopen the country in a safe way prior to having a vaccine is a robust testing and contact tracing system… Continue Reading >

Top 10 Genetic Diagnostics Companies of 2020 – Healthcare Tech Outlook

May 28, 2020 | The ground-breaking Next-Generation Sequencing (NGS) technology with its ultra-high throughput, speed, and data quality has revolutionized genomic and genetic research. A slew of factors is contributing to its soaring popularity. An increase in acceptance of utilization of NGS-based tests in the clinics and several disease treatment options and a decline in NGS capital requirements are among the many. However, these developments present a significant dilemma for the industry. The rapidly growing demand for NGS-based tests is expected to multiply the workload for clinical laboratories in the next four years. But the labor-intensive diagnostic process requires expertise and attention to detail, and there is already a shortage of specific knowledge in the NGS area. Perhaps, the only way to solve this dilemma is automation… Continue Reading >

Golden Helix: Enabling Precision Medicine with Cutting-Edge NGS Technologies – Clinical OMICs

June 15, 2020 | Golden Helix has been delivering industry-leading bioinformatics solutions for the advancement of life science research and translational medicine for over 20 years with 1,000s of users around the world. Their innovative technologies and analytic services empower scientists and healthcare professionals at all levels to derive meaning from the rapidly increasing volumes of genomic data produced from NGS sequencers and microarrays. With their solutions, hundreds of the world’s top hospitals, testing labs, pharmaceutical, biotech, and academic research organizations can harness the full potential of genomics to identify the cause of disease, improve the efficacy and safety of drugs, develop genomic diagnostics, and advance the quest for personalized medicine… Continue Reading >

We hope you enjoyed this Recent Feature Round-Up! If you are interested in reading a few more pieces on Golden Helix, check out our Press Page!

Delaina Hawkins

About Delaina Hawkins

Delaina Hawkins, Director of Marketing & Operations at Golden Helix, joined the team in June of 2017. She is passionate about elevating a company to effectively grow user engagement, build brand loyalty and ultimately drive sales and revenue. When she isn't in the office, she enjoys being outdoors with friends and family.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.